Business – Business Wire Friday, Dec. 09, 2011 0 Comments Research and Markets: Triple Analysis: Leukemia, Lung Cancer and Melanoma E-Mail Print Reprint or license Text Size: DUBLIN — Research and Markets(http://www.researchandmarkets.com/research/3ad9a0/triple_analysis_l) has announced the addition of the “Triple Analysis: Leukemia, Lung Cancer and Melanoma” report to their offering. This triple analysis focuses on cancer [...]

A look at data on how the industry chooses with whom to outsource, and what it really thinks about potential partners. By Paul Thomas, Senior Editor 1 vote Share Print Related RSS Text size: – + A year ago, Nice Insight, a division of the brand and marketing management firm That’s Nice, began using its [...]

Siemens is looking for greater sustainability in healthcare as well, and wants to contribute to carbon dioxide (CO2) savings. An important focus is on taking back and refurbishing medical devices. In the Proven Excellence Program, a quality process specially developed by Siemens, the product lifecycle of these systems is extended, and they are remarketed as [...]

Adapting cost structure; sustaining innovation leadership in a changing environment Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a Group-wide Operational Excellence initiative. In view of mounting pressures to curb healthcare costs – especially in the United States and Europe – together with recent developments in late-stage projects in the Roche pipeline, [...]

Johnson & Johnson is poised for an overhaul of its manufacturing operations as the company strives to leave behind a stream of recalls of its over-the-counter medicines and production setbacks. In order to boost quality the company has decided to put in a place a single, company-wide manufacturing, quality and compliance framework, to be overseen [...]

SAN FRANCISCO, March 23, 2010 — Scientists today described a new ultra-rapid acting mealtime insulin (AFREZZA™) that is orally inhaled for absorption via the lung. Because the insulin is absorbed so rapidly, AFREZZA’s profile closely mimics the normal early insulin response seen in healthy individuals. AFREZZA is awaiting approval by the U. S. Food and [...]

Quality by Design (QbD) is unquestionably ready to help your organization solve the perennial challenges of drug development and manufacturing. The real question is whether your organization is ready for QbD. Answering that question begins with an understanding of QbD basics, benefits, and barriers to implementation, followed by a readiness assessment that can ensure that [...]

A bill designed to give the US Food and Drug Administration greater powers to oversee the pharmaceutical supply chain has been introduced by Colorado Senator Michael Bennett.

Pfizer will cut 6,000 jobs, or 18% of its worldwide workforce, as it pares back operations following last year’s purchase of rival Wyeth. The world’s biggest drugmaker – which sells Viagra and cholesterol drug Lipitor – said yesterday it plans to cease operations at eight plants in the U.S. and Ireland by 2015, and reduce [...]

Pfizer and Washington University plan to work together to find new uses for more than 500 drug compounds under what the drug maker called a first-of-a-kind collaboration between academia and industry. Pfizer plans to give scientists at the St. Louis-based university’s medical school access to the compounds and research data. The compounds are currently or [...]